BRIEF published on 06/18/2025 at 07:05, 1 year 4 months ago PHAXIAM Therapeutics suspends trading of its shares Euronext Paris Innovative Treatments PHAXIAM Suspension Of Quotation Delisting Securities
PRESS RELEASE published on 06/18/2025 at 07:00, 1 year 4 months ago Inside Information / Other news releases PHAXIAM Therapeutics suspends trading shares for delisting on Euronext Paris market. No reimbursement to shareholders. Company focuses on innovative phage-based treatments for resistant bacterial infections Trading Delisting Suspension PHAXIAM Therapeutics Phage-based Treatments
BRIEF published on 06/05/2025 at 07:05, 1 year 4 months ago PHAXIAM Therapeutics Facing Potential Liquidation Amid Court Hearing Postponement Biopharmaceuticals Judicial Liquidation Court Hearing PHAXIAM Therapeutics Euronext Delisting
PRESS RELEASE published on 06/05/2025 at 07:00, 1 year 4 months ago Inside Information / Other news releases PHAXIAM Therapeutics announces new postponement of Offer Review Hearing by Lyon Commercial Court to June 11, 2025. Company to request delisting from Euronext Euronext Delisting Postponement PHAXIAM Therapeutics Lyon Commercial Court
BRIEF published on 03/14/2025 at 17:50, 1 year 7 months ago PHAXIAM Therapeutics seeks buyer in receivership Euronext Paris PHAXIAM Therapeutics Judicial Recovery Looking For A Buyer Extension Of Procedure
PRESS RELEASE published on 03/14/2025 at 17:45, 1 year 7 months ago Inside Information / Other news releases PHAXIAM Therapeutics launches bidding process to find buyers amid receivership, trading of shares to resume on Euronext Paris. Court decides on procedure extension on April 30, 2025 Euronext Paris Receivership PHAXIAM Therapeutics Court Decision Bidding Process
BRIEF published on 03/06/2025 at 18:01, 1 year 7 months ago PHAXIAM Therapeutics Enters Receivership and Delays Financial Results Trading Suspension Financial Results Delay PHAXIAM Receivership Biotech Challenges Court-appointed Administrator
PRESS RELEASE published on 03/06/2025 at 17:56, 1 year 7 months ago Inside Information / Other news releases PHAXIAM Therapeutics announces the opening of a receivership procedure and postponement of its 2024 financial results publication. The company continues operations under observation period Financial Results Biopharmaceutical Company PHAXIAM Therapeutics Receivership Procedure Phage-based Treatments
BRIEF published on 03/06/2025 at 11:45, 1 year 7 months ago Suspension of the Listing of PHAXIAM Therapeutics Euronext Paris Biopharmaceutical PHAXIAM Therapeutics Suspension Of Quotation Resistant Infections
BRIEF published on 12/30/2024 at 17:50, 1 year 9 months ago PHAXIAM Therapeutics: Promising results from the PhagoDAIR pilot study Infection Control PHAXIAM Therapeutics Phase II GLORIA PhagoDAIR Study Anti-S. Aureus Phages
Published on 10/20/2026 at 23:10, 25 minutes ago Polaris Renewable Energy Awards Key Supply Contract and Issues Notice to Proceed on Punta Lima Battery Storage Investment
Published on 10/20/2026 at 22:00, 1 hour 35 minutes ago Eagle Plains Increases Saskatchewan Royalty Portfolio
Published on 10/20/2026 at 20:10, 3 hours 25 minutes ago Torq Resources Completes Extension of Credit Facility
Published on 10/20/2026 at 17:00, 6 hours 35 minutes ago GameSquare Announces The "Grand Theft Auto" Effect
Published on 10/20/2026 at 14:45, 8 hours 50 minutes ago NanoViricides' Revolutionary Broad-Spectrum Drug Candidate NV-387 Has Successfully Demonstrated Excellent Indications for Safety and Toxicology in a Juvenile Mouse Pups Animal Study, Paving the Way for Pediatric Use in Clinical Trials
Published on 10/20/2026 at 19:32, 4 hours 2 minutes ago Aroundtown significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE
Published on 10/20/2026 at 19:31, 4 hours 4 minutes ago Aroundtown significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE
Published on 10/20/2026 at 19:31, 4 hours 4 minutes ago Grand City Properties S.A. acquires 20% stake in LEG Immobilien SE to drive strong FFO growth
Published on 10/20/2026 at 19:29, 4 hours 6 minutes ago Aroundtown SA significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE
Published on 10/20/2026 at 19:29, 4 hours 6 minutes ago Grand City Properties S.A. acquires 20% stake in LEG Immobilien SE to drive strong FFO growth
Published on 10/20/2026 at 19:47, 3 hours 48 minutes ago Compagnie Chargeurs Invest becomes Belgrano and reaches a new milestone in the implementation of its public share buyback offer (OPRA)
Published on 10/20/2026 at 12:36, 10 hours 59 minutes ago CNP Assurances announces the signing of a binding agreement with Prudential Financial to acquire its insurance businesses in Brazil and Mexico
